The stakes of this research are enormous. Genome organization is intimately connected to essential cellular functions such as gene expression, DNA replication, and DNA repair. Enhancers, the distal regulatory elements that boost gene activity, may lie millions of DNA letters away from the genes they control along the linear chromosome, yet they must physically find and contact their targets within the crowded nuclear space. Understanding how the chromatin fiber brings the right pieces together requires more than biology alone; it requires quantitative models in which chromosomes are treated as polymer chains and proteins as interacting particles whose collective behavior can be simulated, perturbed, and compared against experimental data from microscopy and chromosome-conformation assays.

The first pillar of the framework discussed by Fontana and Chiariello is phase separation, the same process that causes oil to bead up in water, here operating on proteins inside the nucleus. Many regulatory proteins carry intrinsically disordered regions that allow them to interact with copies of themselves, forming stable condensates. Well-studied examples include Mediator and RNA polymerase II, which cluster together at active genes, as well as coactivators that assemble at super-enhancers and transcription factors whose activation domains can condense to drive gene expression. At larger scales, phase separation helps build Cajal bodies and the nucleolus, a multi-phase structure assembled from distinct molecular species of proteins and RNA. Crucially, when the phase-separation properties of these proteins go wrong, the result can be disease, ranging from rare genetic disorders involving nucleolar dysfunction to cancer driven by aberrant condensates.

To capture this phenomenon computationally, theorists have built models in which chromatin is represented as a polymer and proteins are represented as particles that bind to it. Some of the simplest versions include only polymer-protein interactions, leaving out direct protein-protein attraction. Even so, these bridging models give rise to what is known as polymer-polymer phase separation, in which the polymer itself nucleates condensates of bound proteins that then glue distant chromatin segments together. Despite their minimalism, such models have successfully reconstructed the three-dimensional structures of real genomic regions, described chromatin remodeling across different cell types, and even tracked how genome architecture is rearranged following viral infections, including SARS-CoV-2.

More realistic systems require explicit protein-protein interactions alongside chromatin-protein affinity, and, in the most complete versions, loop extrusion as well. In loop extrusion, molecular motors of the cohesin or condensin families slide along the chromatin fiber, enlarging DNA loops until they are halted at anchor points, often corresponding to binding sites of the architectural protein CTCF. Single-molecule imaging has now captured this process in real time, and computational studies show that extrusion contributes to global chromosome condensation during mitosis as well as to the local loops and domains that organize the interphase genome. When all these ingredients coexist, the behavior of the system is governed by a set of control parameters, including protein concentration, self-interaction affinity, chromatin affinity, and motor density and processivity, and the resulting equilibrium states fall into complex phase diagrams reminiscent of those studied in condensed matter physics.

One of the most striking predictions to emerge from large-scale molecular dynamics simulations concerns a scenario now called polymer-assisted condensation, or PAC. Simulations revealed that phase-separated condensates can arise in two distinct ways: either spontaneously through strong protein-protein affinity, independently of the polymer, or in a polymer-assisted route in which protein-protein attraction alone is too weak to drive condensation, but binding to chromatin concentrates the proteins enough to tip the system over the threshold. This second mechanism, first predicted computationally and later explored theoretically, has been proposed as a potentially general principle of chromatin organization, with implications for heterochromatin formation and epigenetic memory.

The power of the integrated approach was demonstrated in recent work on PHF13, a protein that binds chromatin enriched with the histone methylation marks H3K4me3 and H3K27me3 and can also self-associate through specific N-terminal sub-domains. Molecular dynamics simulations showed that when both chromatin-protein and protein-protein interactions were enabled at sufficient PHF13 concentration, the modeled polymer collapsed into a compact, roughly spherical globule decorated with PHF13 clusters, mirroring microscopy images of interphase cells overexpressing PHF13, in which chromosomes condense into rounded structures. When the self-interaction domains were disabled in silico, compaction was reduced and condensation disappeared, exactly matching the behavior of engineered PHF13 variants lacking those domains in living cells. The close agreement between simulation and experiment provides a compelling validation of the physics-based framework.

The same modeling philosophy is now being applied to disease. The chimeric protein NUP98-HOXA9, an oncofusion associated with leukemia, can undergo phase separation and bind chromatin, promoting the formation of aberrant loops that bring oncogenes such as PBX3 into contact with distant regulatory elements. Models of the relevant genomic regions accurately recapitulated the aberrant looping patterns observed in experimental Hi-C contact maps from human cells and in single-molecule mobility measurements, while also capturing the interplay between phase separation and loop extrusion that underlies the pathological rewiring. Because altered phase separation has been implicated in cancers and rare genetic diseases, such models offer a route to understanding how molecular-scale misfolding translates into gene misregulation.

The third pillar of the framework concerns the nuclear envelope. The nuclear lamina, a protein network embedded in the inner membrane, adsorbs peripheral chromatin, spatially segregating specific genomic regions from the nuclear interior and repressing their activity. Computational models represent the lamina as an adsorbing membrane that attracts or sterically excludes chromatin segments, with interactions parameterized from DamID profiles that quantify locus-specific lamina association. When loop extrusion and lamina adsorption are combined in a single simulation, the framework accurately reproduces the organization of peripheral loci such as the mouse Sox9 and Kcnj2 region, and tuning chromatin-lamina affinity allows different degrees of peripheral association and distinct cell populations to be described. Simulations of genomic editing, including deletion of CTCF boundary elements, quantitatively matched experimental outcomes, establishing a link between loop extrusion and lamina association even though the two processes act independently.

Fontana and Chiariello conclude that the great advantage of these physics-based models is their versatility: phase separation, loop extrusion, and membrane adsorption can be combined within a single computational framework to describe increasingly detailed biological contexts, at the cost of larger parameter spaces and more complex phase diagrams that molecular dynamics simulations are well suited to explore. Looking forward, the authors point to promising extensions, including modeling pathogenic protein variants, the chromatin changes of ageing, and the architectural disruptions induced by external pathogens such as viruses. As genome-wide datasets grow richer and simulations grow faster, the dream of predicting, and perhaps one day correcting, the physical misfolding events behind human disease moves steadily closer to reality.

Subject of Research: Physics-based computational modeling of chromatin 3D organization through phase separation, loop extrusion, and nuclear lamina adsorption

Article Title: On the physics of chromatin molecular complex: from phase-separation to membrane adsorption

Article References: Fontana, A., & Chiariello, A. M. (2026). On the physics of chromatin molecular complex: from phase-separation to membrane adsorption. Frontiers in Molecular Biosciences, 13, Article 1951961. https://doi.org/10.3389/fmolb.2026.1951961

Image Credits: AI Generated

DOI: 10.3389/fmolb.2026.1951961

Keywords: chromatin, 3D genome organization, phase separation, loop extrusion, polymer physics, nuclear lamina, molecular dynamics, gene regulation, biomolecular condensates, CTCF, cohesin, leukemia

The central premise of the review is that HPV-mediated checkpoint disruption is only the first act. Once the p53 and RB brakes are released, the malignant cell must still stabilize a proliferative, treatment-tolerant state, and the authors propose that this stabilization depends on epigenetic permissiveness and the spatial organization of the genome. Chromatin is not a passive spool of DNA. It is folded into topologically associating domains, or TADs, insulated neighborhoods in which enhancers preferentially contact the promoters they regulate. Structural maintenance of chromosomes complexes, chiefly cohesin, extrude DNA loops that bring distant regulatory elements together, while the insulator protein CTCF anchors domain boundaries. The WAPL cohesin release factor limits how far loops extend, tuning the overall folding landscape. When any of these components are altered, enhancers can be rewired onto inappropriate promoters, a mechanism long implicated in oncogene activation across many cancers.

HPV integration into the host genome is where viral biology and chromatin architecture collide. Integration is not a random insertion event; it frequently disrupts host regulatory regions and places viral and host sequences into new cis-regulatory relationships. Recent work cited in the review shows that the cis-regulatory effect of HPV integration is constrained by pre-existing host chromatin architecture, meaning the local folding context determines which genes a viral integration event can actually activate. Long-read sequencing of cervical cancer cell lines has revealed the structural complexity of these integration junctions, and genome-wide analyses have documented allele-specific impacts of viral-human rearrangements on cancer genome regulation. In effect, the virus hijacks the host’s own enhancer-promoter wiring, and the resulting rewiring can amplify MYC and E2F-centered transcriptional programs that drive uncontrolled proliferation.

The review gives particular attention to MYC, the transcription factor whose amplification has been detected even in preinvasive cervical lesions. MYC operates as a transcriptional amplifier, and tumors with rewired enhancer landscapes can become addicted to this sustained transcriptional output, a concept known as transcriptional addiction. That dependency creates a therapeutic opening. Bromodomain-containing protein 4, a BET family protein that recruits transcriptional machinery to active enhancers, has emerged as a druggable node: experimental studies show that BRD4 inhibition suppresses HPV16 E6 expression and enhances chemotherapy response, and separate work demonstrates that BRD4 inhibition sensitizes cervical cancer cells to radiotherapy by attenuating DNA repair. Early-phase clinical trials of MYC-targeting approaches in solid tumors, such as the peptide-based OMO-103, suggest that the long-undruggable MYC axis is finally becoming addressable.

Cohesin dynamics add another layer of vulnerability. The authors highlight their own prior finding that WAPL, the cohesin release factor, can induce cervical intraepithelial neoplasia in experimental models even without HPV E6 and E7, when modulated by estrogen signaling. This is a striking result because it implies that perturbing the genome’s folding machinery alone can push cervical epithelium toward premalignant states. Conversely, it suggests that cervical cancers may develop dependencies on specific cohesin regulators to maintain their malignant chromatin configuration. Recent single-molecule imaging of loop extrusion in living cells and studies showing extensive mutual influence among SMC complexes are refining how researchers understand these folding dynamics, and the review argues that such dependencies should be systematically screened in cervical cancer models using CRISPR perturbation and dependency mapping resources such as DepMap.

Chromatin remodeling complexes themselves are also implicated. Loss of ARID1A, the AT-rich interaction domain 1A subunit of the SWI/SNF complex, has been linked to tumor progression and adverse prognosis in cervical cancer, and emerging clinical data suggest that ARID1A and B2M mutations, together with antigen presentation pathway status, may predict response to definitive chemoradiotherapy. Histone modification enzymes, including the polycomb methyltransferase EZH2 and the demethylase KDM6A, are altered in HPV E6/E7-expressing keratinocytes, indicating that viral oncoproteins reprogram the epigenome from the earliest stages of infection. Three-dimensional chromatin analyses have additionally identified the transcription factor Sp1 as a mediator that programs and reprograms HPV-host epigenetic architecture in cervical cancer, providing a concrete molecular handle on how viral and host regulatory systems become intertwined.

Non-genetic plasticity is a recurring theme in the review’s account of therapeutic resistance. Cancer cells can evade drugs by reprogramming their transcriptional states without any new mutation, and rare pre-existing cell variants can seed drug-induced reprogramming within heterogeneous populations. Epigenetic plasticity is increasingly recognized as a hallmark that fuels tumor evolution while simultaneously exposing weaknesses. In cervical cancer specifically, single-nucleus and single-cell RNA sequencing studies have revealed heterogeneous microenvironments and distinct drug responses between squamous cell carcinoma and adenocarcinoma, while spatial transcriptomics is mapping how cancer-associated fibroblasts and immune cells shape the transcriptional landscape. Context-dependent signaling through PI3K-AKT, RAS-ERK, NOTCH1, and the Hippo pathway effectors YAP and TAZ, whose roles vary by HPV type, cooperates with chromatin state to determine whether a cell tolerates treatment or dies.

The tumor microenvironment completes the resistance circuit. CXCL8, a chemokine produced within the inflammatory milieu, has been shown to be essential for acquired radioresistance in cervical cancer cells and is proposed as a therapeutic target. HPV-mediated immune evasion mechanisms, the composition of the immune microenvironment, and the cancer-immune set point all influence how patients respond to the checkpoint inhibitor pembrolizumab, which in the phase 3 KEYNOTE-A18 trial improved outcomes when added to chemoradiotherapy for high-risk locally advanced disease. The review argues that chromatin-informed biomarkers, such as enhancer landscapes and chromatin accessibility profiles measured by ATAC-seq, ChIP-seq, and CUT&Tag, should be integrated with microenvironmental data to stratify patients more accurately than viral status alone allows.

Methodologically, the authors lay out an experimentally testable framework that leans on public datasets from The Cancer Genome Atlas and the Gene Expression Omnibus, perturbation-guided prioritization using CRISPR activation and interference screens, and computational tools including compositional perturbation autoencoders and in silico perturbation methods that predict cellular responses to genetic and pharmacological interventions. Multimodal artificial intelligence approaches that combine imaging, genomic, and clinical data are highlighted as a route to precision management, and network pharmacology offers a way to target causal resistance mechanisms rather than symptoms. Crucially, the framework depends on experimentally faithful models: authenticated cervical cancer cell lines, patient-derived organoids that recapitulate cervical tissue dynamics and viral oncogenesis, and patient-derived xenograft-style cultures that can predict sensitivity to chemotherapy and radiation.

The significance of this review lies in its reframing of HPV-driven cervical cancer as a disease of coupled viral and host genome regulation. Rather than treating E6 and E7 expression as the whole story, it positions chromatin architecture, enhancer rewiring, cohesin dynamics, and epigenetic plasticity as the machinery that converts viral checkpoint disruption into stable, adaptable, treatment-resistant malignancy. If the proposed framework holds up under experimental scrutiny, chromatin-informed stratification could identify which patients need intensified or combination therapy, while vulnerabilities in BET proteins, MYC signaling, cohesin regulators, and microenvironmental cytokines could yield rational combination strategies. For a cancer that remains a major global cause of mortality despite vaccination and screening, shifting the therapeutic lens from the viral oncogenes alone to the three-dimensional regulatory genome they exploit may prove a consequential conceptual advance.

Subject of Research: Host chromatin architecture and 3D genome rewiring in HPV-driven cervical cancer and therapeutic resistance

Article Title: Host chromatin architecture in HPV-driven cervical cancer: molecular mechanisms and therapeutic resistance

Article References: Kumagai, K., Suzuki, Y., Kitahara, K., Chiba, A., & Yajima, H. (2026). Host chromatin architecture in HPV-driven cervical cancer: molecular mechanisms and therapeutic resistance. Medical Oncology, 43(11), Article 324. https://doi.org/10.1007/s12032-026-03445-w

Image Credits: AI Generated

DOI: 10.1007/s12032-026-03445-w

Keywords: HPV, cervical cancer, chromatin architecture, 3D genome, enhancer rewiring, cohesin, WAPL, MYC, BRD4, therapeutic resistance, epigenetic plasticity, tumor microenvironment

The research hinged on a technical feat: watching individual nucleosomes, the fundamental repeating units of chromatin, move in real time inside living cells. The team combined single-nucleosome imaging and tracking with super-resolution three-dimensional structured illumination microscopy, or 3D-SIM, which pushes past the classical diffraction limit of light microscopy to resolve chromatin organization at a scale of tens of nanometers. Together these methods allowed the investigators to measure both the local motion of nucleosomes and the three-dimensional morphology of condensed euchromatic domains in the same living cells, before and after acute manipulation of cohesin.

Euchromatin is not a homogeneous soup of DNA and proteins. It is partitioned into domains with distinct physical properties, some of which behave like condensed droplets enriched in transcriptionally active machinery. A central question in the field has been whether these domains are held apart by active mechanisms or whether they self-organize through the physics of phase separation, with weak, multivalent interactions driving chromatin to demix into distinct liquid-like compartments. The new findings point to a decisive role for cohesin in maintaining this compartmentalization, adding a genetic and biochemical handle to what has often been framed as a purely biophysical problem.

The single-nucleosome tracking experiments provided a dynamic readout of chromatin fluidity. By labeling histones sparsely and following their trajectories frame by frame, the researchers could quantify how freely nucleosomes diffuse within their local chromatin environment. In normal cells, nucleosomes within condensed euchromatic domains showed constrained mobility, consistent with a densely packed and relatively stable chromatin fiber. When the investigators acutely depleted cohesin, the picture changed dramatically: nucleosome mobility increased, indicating that the condensed euchromatic domains had become more fluid, more like a liquid and less like a restrained polymer network.

What makes this result particularly striking is what did not change. Overall chromatin compaction, measured as the average density of chromatin within the euchromatic regions, was essentially unaffected by the loss of cohesin. The domains remained condensed; they did not dissolve or decondense. Instead, their internal fluidity rose, and with it their tendency to coalesce. In other words, cohesin does not maintain the physical state of euchromatin by controlling how tightly it is packed. Its role is spatial rather than material: it keeps condensed domains in their proper places, preventing neighboring territories from merging even while each territory stays as compact as before.

Super-resolution 3D-SIM imaging made this loss of spatial control visible. In cohesin-proficient cells, condensed euchromatic domains appeared as discrete, bounded objects distributed through the nuclear interior. After cohesin removal, the boundaries between adjacent domains blurred, and domains that had previously remained separate were observed to fuse locally, producing larger, mixed territories. The consequence of this mixing is not merely cosmetic. The functional identity of chromatin domains depends on their insulation: enhancers, silencers, and other regulatory elements act over defined genomic distances, and the three-dimensional organization of chromatin helps enforce those limits. When domains mix, regulatory inputs can reach genes that were previously shielded from them.

That functional consequence was confirmed at the level of transcription. The researchers found that cohesin loss compromised transcriptional insulation, allowing the transcriptional programs of neighboring domains to interfere with one another. Genes that had been maintained in distinct regulatory environments began to respond to the wrong controls. This connects the physical observation, domain mixing, to a biological output, misregulated gene expression, and suggests that the barrier function of cohesin is not an incidental byproduct of loop extrusion but a property that cells rely on to keep their regulatory circuits orderly.

Cohesin is already famous for its role in genome architecture through the process of loop extrusion, in which the complex translocates along DNA and enlarges loops until halted by boundary elements such as CTCF. This activity organizes the genome into topologically associating domains, or TADs, and its disruption in diseases known as cohesinopathies causes developmental defects. The new work adds a second, complementary dimension to this picture. Beyond extruding loops between distant genomic sites, cohesin locally constrains condensed euchromatin, and these two functions together may explain why mutations affecting cohesin produce such broad and pleiotropic effects on gene expression during development.

The findings also sharpen the ongoing debate about how chromatin compartments form and are maintained. Models based on phase separation predict that chromatin domains with similar biochemical properties should spontaneously coalesce and repel dissimilar ones, with demixing driven by the intrinsic interactions among nucleosomes, histone tails, and associated factors. If phase separation alone were sufficient to maintain euchromatic domains, removing cohesin should not have caused them to merge; their physical similarity should have kept them together but distinct. The observation that cohesin loss increases fluidity and permits mixing suggests that intrinsic chromatin interactions favor coalescence, and that cohesin actively opposes this tendency, fencing off domains that would otherwise blend. Cohesin, in this view, is the factor that prevents local mixing of condensed euchromatin in the crowded nuclear environment.

Technically, the study demonstrates the power of imaging-based approaches that operate in living cells at single-molecule and super-resolution scales simultaneously. Fixed-cell methods capture snapshots of architecture but cannot distinguish between domains that are statically separate and domains that are dynamically prevented from mixing. Single-nucleosome tracking adds the temporal dimension, revealing that cohesin constrains motion rather than compaction, a distinction invisible to purely structural measurements. The combination of these modalities provides a template for future studies of how other nuclear factors, from architectural proteins to RNA polymerase machinery, shape the physical behavior of chromatin in real time.

The broader implications reach into human disease. Cohesin genes are among the most frequently mutated in cancers, and cohesion-related developmental syndromes such as Cornelia de Lange syndrome arise from haploinsufficiency of cohesin components. If part of the pathology of these conditions stems from the loss of transcriptional insulation, then the specific mechanism identified here, increased fluidity and mixing of condensed euchromatic domains, offers a concrete physical picture of how cohesin mutations dysregulate gene expression. It also suggests that the degree of chromatin fluidity could serve as a measurable cellular phenotype, detectable by live-cell imaging, in cells carrying cohesin mutations or in tumors with disrupted cohesin function.

Looking forward, the study raises questions that will drive the next phase of research. How does cohesin physically constrain the mobility of condensed euchromatin, and is this barrier function mediated by the same extrusion activity that forms loops, or by a distinct, stabilizing interaction with chromatin? How many cohesin complexes are required to fence off a single condensed domain, and where do these barrier-forming complexes reside relative to domain boundaries? And do other nuclear factors cooperate with cohesin in maintaining compartmental identity, or does cohesin act largely alone? Answering these questions will require extending the same live-cell, super-resolution toolkit used in this study, but the central message is already clear: the genome’s active regions are kept separate not by the physics of chromatin alone, but by an active, energy-consuming molecular machine that patrols the boundaries between them.

Subject of Research: Cohesin-mediated spatial insulation of condensed euchromatic domains in living human cells

Article Title: Cohesin prevents local mixing of condensed euchromatic domains in living human cells

Article References: Shimazoe, M. A., Iida, S., Minami, K., Higashi, K., Tamura, S., Kobayashi, Y., Fujishiro, S., Xiong, L., Nakazato, K., Ashwin, S. S., Nishiyama, T., Nagata, Y., Kanemaki, M. T., Kawaguchi, A., Ohkawa, Y., Schermelleh, L., Toyoda, A., Xie, L., Kurokawa, K., … Maeshima, K. (2026). Cohesin prevents local mixing of condensed euchromatic domains in living human cells. Nature Genetics, 58(9), 2335-2349. https://doi.org/10.1038/s41588-026-02736-2

Image Credits: AI Generated

DOI: 10.1038/s41588-026-02736-2

Keywords: cohesin, chromatin, euchromatin, single-nucleosome imaging, super-resolution microscopy, 3D-SIM, genome organization, transcriptional insulation, nuclear architecture, phase separation, loop extrusion, epigenetics